2020
DOI: 10.1016/j.jff.2019.103742
|View full text |Cite
|
Sign up to set email alerts
|

7,8-Dihydroxyflavone nano-liposomes decorated by crosslinked and glycosylated lactoferrin: storage stability, antioxidant activity, in vitro release, gastrointestinal digestion and transport in Caco-2 cell monolayers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
51
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 43 publications
(54 citation statements)
references
References 48 publications
3
51
0
Order By: Relevance
“…Nanoliposomes have been widely studied to know their interaction effects in different strains, cultures, and animal models for the development of new drugs, vaccines, improvement of photodynamic and cancer therapy, or even as a tool for the detection of several diseases. Among the current biomedical treatments, chemotherapy sensitization of glioblastoma (75 nm) (Papachristodoulou et al, 2019 ), gastrointestinal disorders (145 nm) (Chen et al, 2020 ), cutaneous (20 nm), and fungal infections (100 nm) (Saadat et al, 2016 ; Bhagat et al, 2019 ), encapsulation of calothrixin B as anticancer agent (108 nm) (Yingyuad et al, 2018 ) are included as some of the successful examples of nanoliposomes as drug delivery mechanisms. Figure 4 Illustrates drug administration and release pathways of nanoliposomes against cancer cells.…”
Section: Biomedical Applications Of Nanoliposomesmentioning
confidence: 99%
“…Nanoliposomes have been widely studied to know their interaction effects in different strains, cultures, and animal models for the development of new drugs, vaccines, improvement of photodynamic and cancer therapy, or even as a tool for the detection of several diseases. Among the current biomedical treatments, chemotherapy sensitization of glioblastoma (75 nm) (Papachristodoulou et al, 2019 ), gastrointestinal disorders (145 nm) (Chen et al, 2020 ), cutaneous (20 nm), and fungal infections (100 nm) (Saadat et al, 2016 ; Bhagat et al, 2019 ), encapsulation of calothrixin B as anticancer agent (108 nm) (Yingyuad et al, 2018 ) are included as some of the successful examples of nanoliposomes as drug delivery mechanisms. Figure 4 Illustrates drug administration and release pathways of nanoliposomes against cancer cells.…”
Section: Biomedical Applications Of Nanoliposomesmentioning
confidence: 99%
“…The digestion assays were carried out by the description of Chen et al. (2020) with some modifications. The samples (20 mL) were added to 20 mL of simulated gastric fluid (SGF, containing 2 mg/mL NaCl, 3.2 mg/mL pepsin, and pH 1.5) and incubated at 37 °C for 2 hr.…”
Section: Methodsmentioning
confidence: 99%
“…The in vitro release behavior was determined using a dialysis method based on the previous research with some modifications (Chen et al., 2020). Briefly, the free OPH and OPH‐Lip were placed in a dialysis bag with 8,000 to 14,000 Da molecular weight cut‐off and incubated at 90 rpm under 37 °C for 12 hr.…”
Section: Methodsmentioning
confidence: 99%
“…Interestingly, it showed the improved antioxidant activity, high bioavailability and better epithelial transport on Caco‐2 cell monolayers than 7,8‐DHF and 7,8‐DHF loaded liposome. Hence, cross‐linked or glycosylated LF coating liposomes are proven to be better delivery systems for 7,8‐DHF and other similar BACs (Yufeng Chen et al., 2020).…”
Section: Applications Of Liposomesmentioning
confidence: 99%
“…Liposome has benefits for several applications in food, functional food and BACs delivery systems (Table 2 and Figure 4). Chen et al (2020) 19.…”
Section: Applications Of Liposomesmentioning
confidence: 99%